It is a chemicals private limited company based in Noida, Uttar Pradesh, India, established in 2019.
2019 | Noida, Uttar Pradesh, India | ActivePhysa Pharmaceuticals Private Limited, a active private limited company, was established on 31 October 2019 in Noida, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230UP2019PTC122896. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sumit Kumar (Additional Director), Prins Kumar (Director), Harpal (Director). Past directors included Himanshu Verma, Hariom Shankar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Near Harish Water Vill - Salarpur, House No - 97, Noida, Uttar Pradesh, 201305.
U24230UP2019PTC122896
122896
31 October 2019
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Physa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Kumar | Additional Director | 03 May 2023 | Current |
| Prins Kumar | Director | 31 Oct 2019 | Current |
| Harpal | Director | 24 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Jun 2022 | Past |
| Pramod Abcsdd | Director | 15 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Physa Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Physa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Physa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Physa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Physa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Physa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Physa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.
Progress on Sumit Kumar was appointed as a Additional Director was appointed as a Additional Director on 03 May 2023 & has been associated with this company since 2 years 7 months . was documented.
The activity Harpal was appointed as a Director was appointed as a Director on 24 Jun 2022 & has been associated with this company since 3 years 6 months . was completed.
The activity Prins Kumar was appointed as a Director was appointed as a Director on 31 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The activity Physa Pharmaceuticals Private Limited was registered on 31 Oct 2019 with Roc Kanpur & aged 6 years 1 month as per MCA records. was completed.
The CIN of Physa Pharmaceuticals Private Limited is U24230UP2019PTC122896.
Physa Pharmaceuticals Private Limited is headquartered at Near Harish Water Vill - Salarpur, House No - 97, Noida, Uttar Pradesh, 201305.
Physa Pharmaceuticals Private Limited was incorporated on 31 October 2019.
The current directors of Physa Pharmaceuticals Private Limited are
The primary industry of Physa Pharmaceuticals Private Limited is Chemicals.
Physa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Physa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Physa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX